ID   MGRN1_HUMAN             Reviewed;         552 AA.
AC   O60291; A4URL3; A4URL4; Q86W76;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   25-JUL-2006, sequence version 2.
DT   10-MAY-2017, entry version 132.
DE   RecName: Full=E3 ubiquitin-protein ligase MGRN1;
DE            EC=2.3.2.27;
DE   AltName: Full=Mahogunin RING finger protein 1;
DE   AltName: Full=RING finger protein 156;
DE   AltName: Full=RING-type E3 ubiquitin transferase MGRN1 {ECO:0000305};
GN   Name=MGRN1; Synonyms=KIAA0544, RNF156;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4), FUNCTION, INTERACTION
RP   WITH MC1R AND MC4R, AND SUBCELLULAR LOCATION.
RX   PubMed=19737927; DOI=10.1074/jbc.M109.028100;
RA   Perez-Oliva A.B., Olivares C., Jimenez-Cervantes C.,
RA   Garcia-Borron J.C.;
RT   "Mahogunin ring finger-1 (MGRN1) E3 ubiquitin ligase inhibits
RT   signaling from melanocortin receptor by competition with Galphas.";
RL   J. Biol. Chem. 284:31714-31725(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Leukocyte;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH TSG101, MUTAGENESIS OF 406-PRO--PRO-409,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=17229889; DOI=10.1091/mbc.E06-09-0787;
RA   Kim B.Y., Olzmann J.A., Barsh G.S., Chin L.S., Li L.;
RT   "Spongiform neurodegeneration-associated E3 ligase Mahogunin
RT   ubiquitylates TSG101 and regulates endosomal trafficking.";
RL   Mol. Biol. Cell 18:1129-1142(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-524, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH TSG101.
RX   PubMed=19703557; DOI=10.1016/j.bbadis.2009.08.009;
RA   Jiao J., Sun K., Walker W.P., Bagher P., Cota C.D., Gunn T.M.;
RT   "Abnormal regulation of TSG101 in mice with spongiform
RT   neurodegeneration.";
RL   Biochim. Biophys. Acta 1792:1027-1035(2009).
RN   [8]
RP   MYRISTOYLATION AT GLY-2.
RX   PubMed=20213681; DOI=10.1002/pmic.200900783;
RA   Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,
RA   Tsunasawa S., Utsumi T.;
RT   "Strategy for comprehensive identification of human N-myristoylated
RT   proteins using an insect cell-free protein synthesis system.";
RL   Proteomics 10:1780-1793(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-524, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase. Mediates monoubiquitination
CC       at multiple sites of TSG101 in the presence of UBE2D1, but not of
CC       UBE2G1, nor UBE2H. Plays a role in the regulation of endosome-to-
CC       lysosome trafficking. Impairs MC1R- and MC4R-signaling by
CC       competing with GNAS-binding to MCRs and inhibiting agonist-induced
CC       cAMP production. Does not inhibit ADRB2-signaling. Does not
CC       promote MC1R ubiquitination. {ECO:0000269|PubMed:17229889,
CC       ECO:0000269|PubMed:19703557, ECO:0000269|PubMed:19737927}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with MC1R and MC4R, but not with TBXA2R.
CC       Interacts with TSG101. Interacts with mislocalized cytosolically
CC       exposed PRNP; this interaction alters MGRN1 subcellular location
CC       and causes lysosomal enlargement (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q99816:TSG101; NbExp=4; IntAct=EBI-2129851, EBI-346882;
CC   -!- SUBCELLULAR LOCATION: Early endosome {ECO:0000269|PubMed:17229889,
CC       ECO:0000269|PubMed:19737927}. Note=The endosomal localization is
CC       dependent on the interaction with TSG101.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm, cytosol. Nucleus.
CC       Note=Translocation from the cytosol to the nucleus is seen only in
CC       the presence of MC1R and MC4R, but not TBXA2R. Excluded from
CC       nucleoli.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm, cytosol. Nucleus.
CC       Note=Translocation from the cytosol to the nucleus is seen only in
CC       the presence of MC1R and MC4R, but not TBXA2R. Excluded from
CC       nucleoli.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cytoplasm, cytosol. Cell
CC       membrane.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Cytoplasm, cytosol. Cell
CC       membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=(+)S;
CC         IsoId=O60291-1; Sequence=Displayed;
CC       Name=2; Synonyms=(+)L;
CC         IsoId=O60291-2; Sequence=VSP_019853;
CC       Name=3; Synonyms=(-)L;
CC         IsoId=O60291-3; Sequence=VSP_036462, VSP_019853;
CC       Name=4; Synonyms=(-)S;
CC         IsoId=O60291-4; Sequence=VSP_036462;
CC   -!- DOMAIN: The RING finger is required for ubiquitin ligase activity.
CC       {ECO:0000250}.
CC   -!- PTM: Autoubiquitinated in vitro. {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25470.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF471397; ABO69623.2; -; mRNA.
DR   EMBL; EF471398; ABO69624.2; -; mRNA.
DR   EMBL; AB011116; BAA25470.1; ALT_INIT; mRNA.
DR   EMBL; AC023830; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050389; AAH50389.1; -; mRNA.
DR   CCDS; CCDS42115.1; -. [O60291-2]
DR   CCDS; CCDS45401.2; -. [O60291-4]
DR   CCDS; CCDS45402.1; -. [O60291-1]
DR   CCDS; CCDS59256.1; -. [O60291-3]
DR   RefSeq; NP_001135761.2; NM_001142289.2. [O60291-3]
DR   RefSeq; NP_001135762.1; NM_001142290.2. [O60291-1]
DR   RefSeq; NP_001135763.2; NM_001142291.2. [O60291-4]
DR   RefSeq; NP_056061.1; NM_015246.3. [O60291-2]
DR   RefSeq; XP_005255277.1; XM_005255220.3. [O60291-1]
DR   RefSeq; XP_005255278.1; XM_005255221.3. [O60291-4]
DR   UniGene; Hs.526494; -.
DR   ProteinModelPortal; O60291; -.
DR   BioGrid; 116890; 45.
DR   IntAct; O60291; 19.
DR   STRING; 9606.ENSP00000262370; -.
DR   iPTMnet; O60291; -.
DR   PhosphoSitePlus; O60291; -.
DR   BioMuta; MGRN1; -.
DR   EPD; O60291; -.
DR   MaxQB; O60291; -.
DR   PaxDb; O60291; -.
DR   PeptideAtlas; O60291; -.
DR   PRIDE; O60291; -.
DR   Ensembl; ENST00000262370; ENSP00000262370; ENSG00000102858. [O60291-2]
DR   Ensembl; ENST00000399577; ENSP00000382487; ENSG00000102858. [O60291-1]
DR   Ensembl; ENST00000415496; ENSP00000393311; ENSG00000102858. [O60291-4]
DR   Ensembl; ENST00000586183; ENSP00000465860; ENSG00000102858. [O60291-4]
DR   Ensembl; ENST00000588994; ENSP00000468819; ENSG00000102858. [O60291-3]
DR   GeneID; 23295; -.
DR   KEGG; hsa:23295; -.
DR   UCSC; uc002cwz.4; human. [O60291-1]
DR   CTD; 23295; -.
DR   DisGeNET; 23295; -.
DR   GeneCards; MGRN1; -.
DR   H-InvDB; HIX0012786; -.
DR   HGNC; HGNC:20254; MGRN1.
DR   HPA; HPA007653; -.
DR   MIM; 607559; gene.
DR   neXtProt; NX_O60291; -.
DR   OpenTargets; ENSG00000102858; -.
DR   PharmGKB; PA134941221; -.
DR   eggNOG; KOG4265; Eukaryota.
DR   eggNOG; ENOG410XRAE; LUCA.
DR   GeneTree; ENSGT00390000009925; -.
DR   HOGENOM; HOG000231196; -.
DR   HOVERGEN; HBG061762; -.
DR   InParanoid; O60291; -.
DR   KO; K10604; -.
DR   PhylomeDB; O60291; -.
DR   TreeFam; TF314969; -.
DR   BRENDA; 6.3.2.19; 2681.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; MGRN1; human.
DR   GenomeRNAi; 23295; -.
DR   PRO; PR:O60291; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000102858; -.
DR   CleanEx; HS_MGRN1; -.
DR   ExpressionAtlas; O60291; baseline and differential.
DR   Genevisible; O60291; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:Ensembl.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB.
DR   GO; GO:0043951; P:negative regulation of cAMP-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IMP:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IEA:Ensembl.
DR   CDD; cd00162; RING; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Cytoplasm;
KW   Endosome; Lipoprotein; Membrane; Metal-binding; Myristate; Nucleus;
KW   Phosphoprotein; Reference proteome; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    552       E3 ubiquitin-protein ligase MGRN1.
FT                                /FTId=PRO_0000246687.
FT   ZN_FING     278    317       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   MOTIF       406    409       Required for TSG101-binding.
FT   MOD_RES     411    411       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9D074}.
FT   MOD_RES     471    471       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D074}.
FT   MOD_RES     524    524       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:20213681}.
FT   VAR_SEQ     356    377       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:19737927}.
FT                                /FTId=VSP_036462.
FT   VAR_SEQ     540    552       ALGPDSCSVGIDE -> GRPTSMETAHGLATTSPTWPPLGG
FT                                PSPDPSAAELTPL (in isoform 2 and isoform
FT                                3). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:19737927}.
FT                                /FTId=VSP_019853.
FT   MUTAGEN     406    409       PSAP->ASAA: Loss of TSG101-binding and
FT                                drastic reduction of TSG101-
FT                                ubiquitination.
FT                                {ECO:0000269|PubMed:17229889}.
FT   CONFLICT    248    248       Y -> H (in Ref. 1; ABO69623/ABO69624).
FT                                {ECO:0000305}.
FT   CONFLICT    537    537       Y -> H (in Ref. 1; ABO69623/ABO69624).
FT                                {ECO:0000305}.
SQ   SEQUENCE   552 AA;  60753 MW;  1F923D25FB49DB4D CRC64;
     MGSILSRRIA GVEDIDIQAN SAYRYPPKSG NYFASHFFMG GEKFDTPHPE GYLFGENMDL
     NFLGSRPVQF PYVTPAPHEP VKTLRSLVNI RKDSLRLVRY KDDADSPTED GDKPRVLYSL
     EFTFDADARV AITIYCQASE EFLNGRAVYS PKSPSLQSET VHYKRGVSQQ FSLPSFKIDF
     SEWKDDELNF DLDRGVFPVV IQAVVDEGDV VEVTGHAHVL LAAFEKHMDG SFSVKPLKQK
     QIVDRVSYLL QEIYGIENKN NQETKPSDDE NSDNSNECVV CLSDLRDTLI LPCRHLCLCT
     SCADTLRYQA NNCPICRLPF RALLQIRAVR KKPGALSPVS FSPVLAQSLE HDEHSCPFKK
     SKPHPASLAS KKPKRETNSD SVPPGYEPIS LLEALNGLRA VSPAIPSAPL YEEITYSGIS
     DGLSQASCPL AAIDHILDSS RQKGRPQSKA PDSTLRSPSS PIHEEDEEKL SEDVDAPPPL
     GGAELALRES SSPESFITEE VDESSSPQQG TRAASIENVL QDSSPEHCGR GPPADIYLPA
     LGPDSCSVGI DE
//
